Logo image of MIR

MIRION TECHNOLOGIES INC (MIR) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MIR - US60471A1016 - Common Stock

23.42 USD
-0.28 (-1.18%)
Last: 12/31/2025, 8:16:03 PM
23.62 USD
+0.2 (+0.85%)
Pre-Market: 1/2/2026, 8:01:09 AM
Fundamental Rating

4

Overall MIR gets a fundamental rating of 4 out of 10. We evaluated MIR against 124 industry peers in the Electronic Equipment, Instruments & Components industry. MIR has only an average score on both its financial health and profitability. MIR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MIR was profitable.
In the past year MIR had a positive cash flow from operations.
In the past 5 years MIR always reported negative net income.
Each year in the past 5 years MIR had a positive operating cash flow.
MIR Yearly Net Income VS EBIT VS OCF VS FCFMIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

MIR has a Return On Assets (0.76%) which is comparable to the rest of the industry.
MIR has a Return On Equity of 1.44%. This is comparable to the rest of the industry: MIR outperforms 50.00% of its industry peers.
MIR has a Return On Invested Capital of 1.38%. This is comparable to the rest of the industry: MIR outperforms 50.81% of its industry peers.
Industry RankSector Rank
ROA 0.76%
ROE 1.44%
ROIC 1.38%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIR Yearly ROA, ROE, ROICMIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 2.94%, MIR is in the better half of the industry, outperforming 62.10% of the companies in the same industry.
Looking at the Operating Margin, with a value of 6.21%, MIR is in the better half of the industry, outperforming 68.55% of the companies in the same industry.
MIR's Operating Margin has declined in the last couple of years.
MIR has a Gross Margin of 47.15%. This is amongst the best in the industry. MIR outperforms 80.65% of its industry peers.
MIR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.21%
PM (TTM) 2.94%
GM 47.15%
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
MIR Yearly Profit, Operating, Gross MarginsMIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

MIR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MIR has more shares outstanding than it did 1 year ago.
The debt/assets ratio for MIR is higher compared to a year ago.
MIR Yearly Shares OutstandingMIR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M
MIR Yearly Total Debt VS Total AssetsMIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.63 indicates that MIR is not a great score, but indicates only limited risk for bankruptcy at the moment.
MIR has a worse Altman-Z score (2.63) than 63.71% of its industry peers.
The Debt to FCF ratio of MIR is 12.91, which is on the high side as it means it would take MIR, 12.91 years of fcf income to pay off all of its debts.
MIR has a Debt to FCF ratio of 12.91. This is comparable to the rest of the industry: MIR outperforms 52.42% of its industry peers.
MIR has a Debt/Equity ratio of 0.65. This is a neutral value indicating MIR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.65, MIR is doing worse than 79.84% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 12.91
Altman-Z 2.63
ROIC/WACC0.14
WACC9.58%
MIR Yearly LT Debt VS Equity VS FCFMIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

MIR has a Current Ratio of 4.83. This indicates that MIR is financially healthy and has no problem in meeting its short term obligations.
MIR's Current ratio of 4.83 is amongst the best of the industry. MIR outperforms 80.65% of its industry peers.
MIR has a Quick Ratio of 4.32. This indicates that MIR is financially healthy and has no problem in meeting its short term obligations.
MIR has a better Quick ratio (4.32) than 80.65% of its industry peers.
Industry RankSector Rank
Current Ratio 4.83
Quick Ratio 4.32
MIR Yearly Current Assets VS Current LiabilitesMIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

MIR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.21%, which is quite impressive.
Looking at the last year, MIR shows a small growth in Revenue. The Revenue has grown by 7.81% in the last year.
MIR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.36% yearly.
EPS 1Y (TTM)28.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)7.81%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%7.88%

3.2 Future

MIR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.78% yearly.
The Revenue is expected to grow by 13.15% on average over the next years. This is quite good.
EPS Next Y20.21%
EPS Next 2Y21.79%
EPS Next 3Y20.78%
EPS Next 5YN/A
Revenue Next Year8.85%
Revenue Next 2Y15.79%
Revenue Next 3Y13.15%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MIR Yearly Revenue VS EstimatesMIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MIR Yearly EPS VS EstimatesMIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 46.84, the valuation of MIR can be described as expensive.
MIR's Price/Earnings ratio is in line with the industry average.
MIR is valuated expensively when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
MIR is valuated quite expensively with a Price/Forward Earnings ratio of 38.51.
MIR's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.13. MIR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 46.84
Fwd PE 38.51
MIR Price Earnings VS Forward Price EarningsMIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MIR.
MIR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 64.05
EV/EBITDA 32.1
MIR Per share dataMIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as MIR's earnings are expected to grow with 20.78% in the coming years.
PEG (NY)2.32
PEG (5Y)N/A
EPS Next 2Y21.79%
EPS Next 3Y20.78%

0

5. Dividend

5.1 Amount

No dividends for MIR!.
Industry RankSector Rank
Dividend Yield 0%

MIRION TECHNOLOGIES INC

NYSE:MIR (12/31/2025, 8:16:03 PM)

Premarket: 23.62 +0.2 (+0.85%)

23.42

-0.28 (-1.18%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-28 2025-10-28/amc
Earnings (Next)02-09 2026-02-09/bmo
Inst Owners101.68%
Inst Owner Change30%
Ins Owners3.76%
Ins Owner Change-3.7%
Market Cap5.94B
Revenue(TTM)902.30M
Net Income(TTM)26.50M
Analysts83.64
Price Target31.24 (33.39%)
Short Float %8.85%
Short Ratio6.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.64%
Min EPS beat(2)8.05%
Max EPS beat(2)21.24%
EPS beat(4)4
Avg EPS beat(4)17.53%
Min EPS beat(4)8.05%
Max EPS beat(4)26.94%
EPS beat(8)6
Avg EPS beat(8)11.89%
EPS beat(12)9
Avg EPS beat(12)11.92%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.75%
Min Revenue beat(2)-0.57%
Max Revenue beat(2)2.07%
Revenue beat(4)2
Avg Revenue beat(4)0.98%
Min Revenue beat(4)-0.57%
Max Revenue beat(4)2.76%
Revenue beat(8)4
Avg Revenue beat(8)0.7%
Revenue beat(12)8
Avg Revenue beat(12)1.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.11%
PT rev (3m)33.15%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)-8.95%
EPS NY rev (1m)-0.67%
EPS NY rev (3m)0.76%
Revenue NQ rev (1m)1.85%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)0.51%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 46.84
Fwd PE 38.51
P/S 6.59
P/FCF 64.05
P/OCF 45.34
P/B 3.23
P/tB N/A
EV/EBITDA 32.1
EPS(TTM)0.5
EY2.13%
EPS(NY)0.61
Fwd EY2.6%
FCF(TTM)0.37
FCFY1.56%
OCF(TTM)0.52
OCFY2.21%
SpS3.56
BVpS7.25
TBVpS-0.26
PEG (NY)2.32
PEG (5Y)N/A
Graham Number9.03
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 1.44%
ROCE 1.75%
ROIC 1.38%
ROICexc 1.95%
ROICexgc 12.22%
OM 6.21%
PM (TTM) 2.94%
GM 47.15%
FCFM 10.28%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y18.71%
ROICexgc growth 5YN/A
ROICexc growth 3Y10.74%
ROICexc growth 5YN/A
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
F-Score6
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 12.91
Debt/EBITDA 6.2
Cap/Depr 27.96%
Cap/Sales 4.24%
Interest Coverage 1.32
Cash Conversion 67.93%
Profit Quality 350.19%
Current Ratio 4.83
Quick Ratio 4.32
Altman-Z 2.63
F-Score6
WACC9.58%
ROIC/WACC0.14
Cap/Depr(3y)24.94%
Cap/Depr(5y)26.34%
Cap/Sales(3y)5.02%
Cap/Sales(5y)4.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y20.21%
EPS Next 2Y21.79%
EPS Next 3Y20.78%
EPS Next 5YN/A
Revenue 1Y (TTM)7.81%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%7.88%
Revenue Next Year8.85%
Revenue Next 2Y15.79%
Revenue Next 3Y13.15%
Revenue Next 5YN/A
EBIT growth 1Y362.81%
EBIT growth 3Y33.25%
EBIT growth 5Y-1.65%
EBIT Next Year481.12%
EBIT Next 3Y104.61%
EBIT Next 5YN/A
FCF growth 1Y455.69%
FCF growth 3Y18.28%
FCF growth 5YN/A
OCF growth 1Y145.51%
OCF growth 3Y22.74%
OCF growth 5Y46.47%

MIRION TECHNOLOGIES INC / MIR FAQ

What is the fundamental rating for MIR stock?

ChartMill assigns a fundamental rating of 4 / 10 to MIR.


Can you provide the valuation status for MIRION TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 2 / 10 to MIRION TECHNOLOGIES INC (MIR). This can be considered as Overvalued.


How profitable is MIRION TECHNOLOGIES INC (MIR) stock?

MIRION TECHNOLOGIES INC (MIR) has a profitability rating of 4 / 10.


What is the financial health of MIRION TECHNOLOGIES INC (MIR) stock?

The financial health rating of MIRION TECHNOLOGIES INC (MIR) is 4 / 10.